8-KItem 5.02 · Officer/Director ChangeItem 7.01 · Reg FD DisclosureItem 8.01 · Other EventsItem 9.01 · Financial Statements
Boston Scientific ($BSX) appointed Ms.
Filed with the SEC on · Summarized by InvestorsBot
Boston Scientific ($BSX) appointed Ms. Smith and Mr. Weber to its Board; press release issued Feb 23, 2026 and furnished as Exhibit 99.1 to the Form 8‑K. 🧾🏥 #BoardAppointments #MedTech
8‑K Item 7.01: Press release furnished (Exhibit 99.1). Disclosure is not "filed" under Section 18 of the Exchange Act and is not incorporated by reference in other filings absent explicit reference. $BSX 🔍📄 #RegulationFD #CorporateGovernance
Item 7.01 provides the appointments only; no transaction, compensation or additional director detail included in the Form 8‑K — review Exhibit 99.1 for background on the new directors. $BSX 📑👥 #InvestorAlert #Governance